<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02613806</url>
  </required_header>
  <id_info>
    <org_study_id>CYYYMZK-08</org_study_id>
    <nct_id>NCT02613806</nct_id>
  </id_info>
  <brief_title>Effects of Dexmedetomidine on Cough Response and Postoperative Recovery Quality in Patients Undergoing Thyroid Surgery With General Anesthesia</brief_title>
  <official_title>Effects of Dexmedetomidine on Cough Response and Postoperative Recovery Quality in Patients Undergoing Thyroid Surgery With General anesthesia---a Randomized Control Double-Blind Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Chongqing Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coughing is a common adverse reaction of thyroid surgery,which could result in postoperative
      bleeding.Postoperative bleeding is a serious and potentially life-threatening
      complication，which could result in acute upper airway obstruction due to neck hematoma and
      increase the need for re-operation.The purpose of this study is to investigate whether
      dexmedetomidine can reduce the incidence of postoperative coughing and contribute to
      postoperative recovery in patients undergoing tyroid surgery with general anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thyroid surgery is a common clinical surgery,the incidence of postoperative coughing is up to
      32.4%.Coughing response could result in postoperative bleeding,even cause respiratory tract
      obstruction,affect patients' postoperative recovery .Dexmedetomidine,an α2 adrenergic
      agonist,has hypnotic,analgesic, anxiolytic,antisympathetic effects,which could facilitate the
      sedation of patients while maintaining their consciousness and keep respiration and
      circulation stable .For these benefits,dexmedetomidine was widely used for general
      anesthesia.However,whether dexmedetomidine can reduce the incidence of postoperative coughing
      is unclear.Therefore,the investigators conduct this randomized controlled double-blind
      trial,to investigate the effects of dexmedetomidine on coughing and postoperative recovery
      quality in patients undergoing tyroid surgery with general anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of coughing</measure>
    <time_frame>within 48 hours postoperatively</time_frame>
    <description>coughing will be observed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>coughing on a four-point scale</measure>
    <time_frame>within 48 hours postoperatively</time_frame>
    <description>coughing on a four-point scale will be measured within 48 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the eyes opening time</measure>
    <time_frame>within 48 hours postoperatively</time_frame>
    <description>the eyes opening time will be observed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the time of extubation</measure>
    <time_frame>within 48 hours postoperatively</time_frame>
    <description>the time of extubation will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale (VAS)</measure>
    <time_frame>at 30 minutes after extubation</time_frame>
    <description>visual analogue scale will be measured at 30 minutes after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sedation-agitation scale(SAS)</measure>
    <time_frame>at 30 minutes after extubation</time_frame>
    <description>sedation-agitation scale will be measured at 30 minutes after extubation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">118</enrollment>
  <condition>Coughing Response</condition>
  <condition>Thyroid Surgery</condition>
  <condition>General Anesthesia</condition>
  <arm_group>
    <arm_group_label>D group (dexmedetomidine)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmeditomidine 0.2 ug/kg·h will be administered to participants by intravenous infusion with microperfusion pump at the beginning of the surgery,and continued till end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C group (saline)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients received equal volume normal saline by intravenous infusion at the beginning of the surgery,and continued till end of surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmeditomidine</intervention_name>
    <description>Dexmeditomidine 0.2 ug/kg·h will be administered to participants by intravenous infusion at the beginning of the surgery,and continued till end of surgery.</description>
    <arm_group_label>D group (dexmedetomidine)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>Isovolumetric normal saline will be administered to participants by intravenous infusion at the beginning of the surgery,and continued till end of surgery.</description>
    <arm_group_label>C group (saline)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged from 18 to 65 years old

          2. American Society of Anesthesiologists (ASA) physical statusⅠor Ⅱ

          3. Diagnosed by B ultrasonic or tissue biopsy show that patients thyrophyma,thyroid
             cancer,thyroid nodule,etc,who need to accept thyroid surgery

        Exclusion Criteria:

          1. large goiter or hyperthyroidism

          2. Preoperative coughing caused by primary diseases of patients

          3. Ⅱdegrees above atrioventricular block

          4. Allergy to anesthesia

          5. History of diabetes

          6. Pregnant women

          7. Serious mental disease

          8. History of alcohol or drug abuse

          9. Severe heart renal or liver dysfunction

         10. The presence of an upper respiratory infection

         11. Asthma

         12. Anticipated difficult airway
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Su Min</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Chongqing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yanping Zhang, Master</last_name>
    <phone>023-89011061</phone>
    <email>398254227@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Su Min, MD.</last_name>
      <phone>+86-23-89011068</phone>
      <email>ms89011068@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Bergese SD, Khabiri B, Roberts WD, Howie MB, McSweeney TD, Gerhardt MA. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth. 2007 Mar;19(2):141-4. Erratum in: J Clin Anesth. 2007 Jun;19(4):323.</citation>
    <PMID>17379129</PMID>
  </reference>
  <reference>
    <citation>Kaya FN, Yavascaoglu B, Turker G, Yildirim A, Gurbet A, Mogol EB, Ozcan B. Intravenous dexmedetomidine, but not midazolam, prolongs bupivacaine spinal anesthesia. Can J Anaesth. 2010 Jan;57(1):39-45. doi: 10.1007/s12630-009-9231-6. Epub 2009 Dec 29.</citation>
    <PMID>20039221</PMID>
  </reference>
  <reference>
    <citation>Kiray A, Naderi S, Ergur I, Korman E. Surgical anatomy of the internal branch of the superior laryngeal nerve. Eur Spine J. 2006 Sep;15(9):1320-5. Epub 2006 Jan 5.</citation>
    <PMID>16402208</PMID>
  </reference>
  <reference>
    <citation>Kamibayashi T, Maze M. Clinical uses of alpha2 -adrenergic agonists. Anesthesiology. 2000 Nov;93(5):1345-9. Review.</citation>
    <PMID>11046225</PMID>
  </reference>
  <reference>
    <citation>Bekker A, Haile M, Kline R, Didehvar S, Babu R, Martiniuk F, Urban M. The effect of intraoperative infusion of dexmedetomidine on the quality of recovery after major spinal surgery. J Neurosurg Anesthesiol. 2013 Jan;25(1):16-24. doi: 10.1097/ANA.0b013e31826318af.</citation>
    <PMID>22824921</PMID>
  </reference>
  <reference>
    <citation>Ham SY, Kim JE, Park C, Shin MJ, Shim YH. Dexmedetomidine does not reduce emergence agitation in adults following orthognathic surgery. Acta Anaesthesiol Scand. 2014 Sep;58(8):955-60. doi: 10.1111/aas.12379.</citation>
    <PMID>25132201</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2015</study_first_submitted>
  <study_first_submitted_qc>November 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2015</study_first_posted>
  <last_update_submitted>November 23, 2015</last_update_submitted>
  <last_update_submitted_qc>November 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Min Su</investigator_full_name>
    <investigator_title>The Department of Anesthesia and Pain Medicine</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Coughing Response</keyword>
  <keyword>Postoperative Recovery Quality</keyword>
  <keyword>Thyroid Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

